Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Long-Term Deferred Tax (2017 - 2025)

Bioceres Crop Solutions' Long-Term Deferred Tax history spans 6 years, with the latest figure at $7.3 million for Q2 2023.

  • For Q2 2023, Long-Term Deferred Tax rose 82.31% year-over-year to $7.3 million; the TTM value through Jun 2023 reached $7.3 million, up 82.31%, while the annual FY2023 figure was $7.3 million, 82.31% up from the prior year.
  • Long-Term Deferred Tax for Q2 2023 was $7.3 million at Bioceres Crop Solutions, up from $4.0 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $7.3 million in Q2 2023 and bottomed at $2.7 million in Q2 2020.
  • The 4-year median for Long-Term Deferred Tax is $3.6 million (2021), against an average of $4.3 million.
  • The largest annual shift saw Long-Term Deferred Tax rose 21.73% in 2021 before it skyrocketed 82.31% in 2023.
  • A 4-year view of Long-Term Deferred Tax shows it stood at $2.7 million in 2020, then rose by 21.73% to $3.3 million in 2021, then grew by 22.36% to $4.0 million in 2022, then surged by 82.31% to $7.3 million in 2023.
  • Per Business Quant, the three most recent readings for BIOX's Long-Term Deferred Tax are $7.3 million (Q2 2023), $4.0 million (Q2 2022), and $3.3 million (Q2 2021).